Humacyte, Inc. (HUMA)
NASDAQ: HUMA · IEX Real-Time Price · USD
5.11
-0.26 (-4.84%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Humacyte Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
183
Market Cap
608.52M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 1.57M | 302.00K | 23.91% |
Dec 31, 2021 | 1.26M | -228.00K | -15.29% |
Dec 31, 2020 | 1.49M | -4.70M | -75.90% |
Dec 31, 2019 | 6.19M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Definitive Healthcare | 255.69M |
Travere Therapeutics | 183.23M |
Weave Communications | 178.08M |
Standard BioTools | 126.76M |
Arcturus Therapeutics Holdings | 124.53M |
Wave Life Sciences | 112.91M |
HUMA News
- 1 day ago - Humacyte wins special advanced-therapy designation for ATEV - Invezz
- 1 day ago - Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA's Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD) - GlobeNewsWire
- 4 weeks ago - Humacyte (HUMA) stock price is pumping but 1 key risk remain - Invezz
- 4 weeks ago - Humacyte to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Humacyte to Participate at Upcoming Investor Conferences in May - GlobeNewsWire
- 7 weeks ago - Humacyte First Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 2 months ago - Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024 - GlobeNewsWire
- 2 months ago - Here's why the Humacyte (HUMA) stock price is pumping - Invezz